CTT Pharmaceutical Holdings, Inc. (CTTH)
0.055
0.00 (0.00%)
USD |
OTCM |
Oct 22, 16:00
CTT Pharmaceutical Holdings Debt to Equity Ratio : 0.7462 for June 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.7462 |
| March 31, 2026 | 0.4552 |
| December 31, 2025 | 0.3406 |
| September 30, 2025 | 0.2078 |
| June 30, 2025 | 0.2119 |
| March 31, 2025 | 0.1946 |
| December 31, 2024 | 0.5248 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | -0.8594 |
| March 31, 2024 | -0.5023 |
| December 31, 2023 | 0.1817 |
| September 30, 2023 | -0.5648 |
| June 30, 2023 | -0.5435 |
| March 31, 2023 | -1.042 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.0498 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.0646 |
| March 31, 2018 | -0.45 |
| December 31, 2017 | -0.6518 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.8748 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | -0.276 |
| June 30, 2016 | -0.4841 |
| March 31, 2016 | 1.255 |
| December 31, 2015 | 0.2599 |
| September 30, 2015 | 0.1187 |
| June 30, 2015 | 0.0898 |
| March 31, 2015 | 0.2851 |
| December 31, 2014 | 0.1487 |
| September 30, 2014 | 14.39 |
| June 30, 2014 | 1.402 |
| March 31, 2014 | -0.8279 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ANI Pharmaceuticals, Inc. | 1.022 |
| Corcept Therapeutics, Inc. | 0.0133 |
| Veru, Inc. | 0.0945 |
| Johnson & Johnson | 0.5477 |
| Eli Lilly & Co. | 1.621 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 0.0674M |
| Total Liabilities (Quarterly) | 0.0414M |
| Shareholders Equity (Quarterly) | 0.026M |
| Net Debt Paydown Yield | -0.01% |